FilingPulse

MGX insider transaction filings

Metagenomi Therapeutics, Inc. — 38 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-11. Screen MGX transaction legs live →

FiledFormInsiderReported transactionsSource
2026-06-114Eckhardt Juergen — DirectorGrant/award (A): 21,000 (derivative) @ $0EDGAR
2026-06-114Reid Laurence — DirectorGrant/award (A): 17,400 (derivative) @ $0EDGAR
2026-06-114Dere Willard H — DirectorGrant/award (A): 21,000 (derivative) @ $0EDGAR
2026-06-114BJERKHOLT ERIC — DirectorGrant/award (A): 21,000 (derivative) @ $0EDGAR
2026-06-104Wapnick Pamela — Chief Financial OfficerSale (S): 2,884 @ $1.30EDGAR
2026-06-104Irish Jian — See Remarks, DirectorSale (S): 3,737 @ $1.30EDGAR
2026-06-104Wein Matthew — See RemarksSale (S): 558 @ $1.30EDGAR
2026-04-034Irish Jian — See Remarks, DirectorGrant/award (A): 46,000 @ $0 · Grant/award (A): 276,000 (derivative) @ $0EDGAR
2026-04-034Wein Matthew — See RemarksGrant/award (A): 11,000 @ $0 · Grant/award (A): 68,000 (derivative) @ $0EDGAR
2026-04-034Wapnick Pamela — Chief Financial OfficerGrant/award (A): 24,000 @ $0 · Grant/award (A): 144,000 (derivative) @ $0EDGAR
2026-03-094Wapnick Pamela — Chief Financial OfficerSale (S): 1,581 @ $1.60EDGAR
2026-03-094Wein Matthew — See RemarksSale (S): 482 @ $1.60EDGAR
2026-03-094Irish Jian — Chief Executive Officer, DirectorGift (G): 228,462 @ $0 · Sale (S): 1,607 @ $1.60EDGAR
2025-12-084Thomas Brian C. — DirectorSale (S): 3,830 @ $1.77EDGAR
2025-12-084Wein Matthew — See RemarksSale (S): 199 @ $1.77EDGAR
2025-12-084Wapnick Pamela — Chief Financial OfficerSale (S): 1,576 @ $1.77EDGAR
2025-12-084Irish Jian — Chief Executive Officer, DirectorSale (S): 1,602 @ $1.77EDGAR
2025-12-014Thomas Brian C. — DirectorSale (S): 2,701 @ $1.81EDGAR
2025-12-014Wapnick Pamela — Chief Financial OfficerSale (S): 1,576 @ $1.81 · Grant/award (A): 120,000 @ $1.60EDGAR
2025-12-014Irish Jian — Chief Executive Officer, DirectorSale (S): 1,602 @ $1.81 · Grant/award (A): 37,500 @ $1.60 · Grant/award (A): 211,000 @ $1.60 · Grant/award (A): 225,000 (derivative) @ $0EDGAR
2025-12-014Wein Matthew — See RemarksSale (S): 199 @ $1.81 · Grant/award (A): 96,000 @ $1.60EDGAR
2025-09-024Reid Laurence — DirectorGrant/award (A): 42,000 (derivative) @ $0EDGAR
2025-06-124Eckhardt Juergen — DirectorGrant/award (A): 21,000 (derivative) @ $0EDGAR
2025-06-124Dere Willard H — DirectorGrant/award (A): 21,000 (derivative) @ $0EDGAR
2025-06-124BJERKHOLT ERIC — DirectorGrant/award (A): 8,572 (derivative) @ $0EDGAR
2025-06-094Wein Matthew — See RemarksSale (S): 199 @ $1.75EDGAR
2025-06-094Wapnick Pamela — Chief Financial OfficerSale (S): 1,576 @ $1.75EDGAR
2025-06-094Thomas Brian C. — Chief Executive Officer, DirectorSale (S): 10,785 @ $1.75EDGAR
2025-06-094Irish Jian — See Remarks, DirectorSale (S): 6,390 @ $1.75EDGAR
2025-06-094Noonberg Sarah B. — Chief Medical OfficerSale (S): 5,239 @ $1.75EDGAR
2025-04-034Wapnick Pamela — Chief Financial OfficerGrant/award (A): 14,000 @ $0 · Grant/award (A): 84,000 (derivative) @ $0EDGAR
2025-04-034Thomas Brian C. — Chief Executive Officer, DirectorGrant/award (A): 32,000 @ $0 · Grant/award (A): 196,000 (derivative) @ $0EDGAR
2025-04-034Irish Jian — See Remarks, DirectorGrant/award (A): 23,000 @ $0 · Grant/award (A): 140,000 (derivative) @ $0EDGAR
2025-04-034Wein Matthew — See RemarksGrant/award (A): 3,650 @ $0 · Grant/award (A): 3,775 @ $0 · Grant/award (A): 21,875 (derivative) @ $0 · Grant/award (A): 22,725 (derivative) @ $0EDGAR
2025-04-034Noonberg Sarah B. — Chief Medical OfficerGrant/award (A): 14,000 @ $0 · Grant/award (A): 84,000 (derivative) @ $0EDGAR
2025-03-074Wein Matthew — See RemarksSale (S): 930 @ $1.87EDGAR
2025-03-074Wapnick Pamela — Chief Financial OfficerSale (S): 1,808 @ $1.87EDGAR
2025-02-054BJERKHOLT ERIC — DirectorGrant/award (A): 42,000 (derivative) @ $0EDGAR

Recent 8-K events — Metagenomi Therapeutics, Inc.

FiledFormItems reportedSource
2026-08-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-108-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders		EDGAR
2026-05-118-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-03-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-01-128-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2025-11-128-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2025-10-018-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement		EDGAR
2025-08-128-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2025-06-118-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2025-05-148-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=MGX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →